Anti-Ro52 antibodies in idiopathic inflammatory myopathies: clinical significance across myositis-specific antibody–defined subgroups

Qi Pan, Shuai Li, Xinyue Guo, Shanshan Li, Yiran Chen, Huihui Ji, Xiaoqin Luo, Yunfeng Dai, Longyang Zhu, Chen Zong, Lin Luo, Ying Li, Xinxin Zhang, Xiaoming Shu, Xin Lu, Guochun Wang, Qinglin Peng

Open source

DOI
10.1093/rheumatology/keag462
Published
2026-08-26
Container
Rheumatology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag462,
  title = {Anti-Ro52 antibodies in idiopathic inflammatory myopathies: clinical significance across myositis-specific antibody–defined subgroups},
  author = {Qi Pan and Shuai Li and Xinyue Guo and Shanshan Li and Yiran Chen and Huihui Ji and Xiaoqin Luo and Yunfeng Dai and Longyang Zhu and Chen Zong and Lin Luo and Ying Li and Xinxin Zhang and Xiaoming Shu and Xin Lu and Guochun Wang and Qinglin Peng},
  year = {2026},
  journal = {Rheumatology},
  doi = {10.1093/rheumatology/keag462},
  url = {https://doi.org/10.1093/rheumatology/keag462}
}

RIS

TY  - JOUR
TI  - Anti-Ro52 antibodies in idiopathic inflammatory myopathies: clinical significance across myositis-specific antibody–defined subgroups
AU  - Qi Pan
AU  - Shuai Li
AU  - Xinyue Guo
AU  - Shanshan Li
AU  - Yiran Chen
AU  - Huihui Ji
AU  - Xiaoqin Luo
AU  - Yunfeng Dai
AU  - Longyang Zhu
AU  - Chen Zong
AU  - Lin Luo
AU  - Ying Li
AU  - Xinxin Zhang
AU  - Xiaoming Shu
AU  - Xin Lu
AU  - Guochun Wang
AU  - Qinglin Peng
PY  - 2026
JO  - Rheumatology
DO  - 10.1093/rheumatology/keag462
UR  - https://doi.org/10.1093/rheumatology/keag462
ER  - 

APA

Pan, Q., Li, S., Guo, X., Li, S., Chen, Y., Ji, H., Luo, X., Dai, Y., Zhu, L., Zong, C., Luo, L., Li, Y., Zhang, X., Shu, X., Lu, X., Wang, G., & Peng, Q. (2026). Anti-Ro52 antibodies in idiopathic inflammatory myopathies: clinical significance across myositis-specific antibody–defined subgroups. Rheumatology. https://doi.org/10.1093/rheumatology/keag462

Source records